Previous close | 1.9500 |
Open | 1.9000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 22.50 |
Expiry date | 2024-10-18 |
Day's range | 1.9000 - 1.9500 |
Contract range | N/A |
Volume | |
Open interest | 233 |
PALO ALTO, Calif., May 31, 2024--Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced its inclusion in the fourth-annual TIME100 Most Influential Companies list, highlighting companies making an extraordinary impact around the world.
PALO ALTO, Calif., May 30, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data from 16 studies highlighting the role of Guardant blood tests and real-world data in advancing precision oncology and cancer screening at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting, May 31-June 4 in Chicago.
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?